CN100427593C - Enzyme-immobilized silk fibroin nanoparticles and preparation method thereof - Google Patents
Enzyme-immobilized silk fibroin nanoparticles and preparation method thereof Download PDFInfo
- Publication number
- CN100427593C CN100427593C CNB2006100391918A CN200610039191A CN100427593C CN 100427593 C CN100427593 C CN 100427593C CN B2006100391918 A CNB2006100391918 A CN B2006100391918A CN 200610039191 A CN200610039191 A CN 200610039191A CN 100427593 C CN100427593 C CN 100427593C
- Authority
- CN
- China
- Prior art keywords
- enzyme
- silk fibroin
- immobilized
- silk
- organic solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108010022355 Fibroins Proteins 0.000 title claims abstract description 124
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000002105 nanoparticle Substances 0.000 title abstract description 39
- 102000004190 Enzymes Human genes 0.000 claims abstract description 77
- 108090000790 Enzymes Proteins 0.000 claims abstract description 77
- 108010093096 Immobilized Enzymes Proteins 0.000 claims abstract description 52
- 239000003960 organic solvent Substances 0.000 claims abstract description 31
- 239000002245 particle Substances 0.000 claims abstract description 15
- 239000000243 solution Substances 0.000 claims description 30
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 21
- 239000000725 suspension Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000011259 mixed solution Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 4
- 102000004195 Isomerases Human genes 0.000 claims description 3
- 108090000769 Isomerases Proteins 0.000 claims description 3
- 239000012798 spherical particle Substances 0.000 claims description 2
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 claims 2
- 101710157860 Oxydoreductase Proteins 0.000 claims 2
- 241000237502 Ostreidae Species 0.000 claims 1
- 235000020636 oyster Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 39
- 238000011084 recovery Methods 0.000 abstract description 17
- 230000036425 denaturation Effects 0.000 abstract description 5
- 238000004925 denaturation Methods 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 4
- 108091005804 Peptidases Proteins 0.000 abstract description 3
- 239000004365 Protease Substances 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 238000001727 in vivo Methods 0.000 abstract description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract description 2
- 230000005847 immunogenicity Effects 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract 1
- 239000002778 food additive Substances 0.000 abstract 1
- 235000013373 food additive Nutrition 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000003262 industrial enzyme Substances 0.000 abstract 1
- 239000011859 microparticle Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 64
- 239000000843 powder Substances 0.000 description 21
- 239000004366 Glucose oxidase Substances 0.000 description 14
- 108010015776 Glucose oxidase Proteins 0.000 description 14
- 229940116332 glucose oxidase Drugs 0.000 description 14
- 235000019420 glucose oxidase Nutrition 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 108010073038 Penicillin Amidase Proteins 0.000 description 9
- 102000019197 Superoxide Dismutase Human genes 0.000 description 9
- 108010012715 Superoxide dismutase Proteins 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 description 6
- 108010024976 Asparaginase Proteins 0.000 description 6
- 230000002776 aggregation Effects 0.000 description 5
- 238000004220 aggregation Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000005185 salting out Methods 0.000 description 4
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 description 3
- NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 108010013296 Sericins Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000002189 fluorescence spectrum Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000009366 sericulture Methods 0.000 description 3
- 238000009777 vacuum freeze-drying Methods 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 229950006191 gluconic acid Drugs 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 238000009775 high-speed stirring Methods 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000003791 organic solvent mixture Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 241000255794 Bombyx mandarina Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- FNZDTPAALYMECS-UHFFFAOYSA-M O.CO.[Br-].[Li+] Chemical compound O.CO.[Br-].[Li+] FNZDTPAALYMECS-UHFFFAOYSA-M 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- IYNDLOXRXUOGIU-LQDWTQKMSA-M benzylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 IYNDLOXRXUOGIU-LQDWTQKMSA-M 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000010390 livzon Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 230000001875 tumorinhibitory effect Effects 0.000 description 1
- 239000011882 ultra-fine particle Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种用蚕丝丝素制造固定化酶的丝素纳米颗粒及其制备方法,属于生物技术酶工程领域。其技术方案是:将酶与水溶性的再生丝素溶液充分混合后,注入到高速搅动的过量水溶性有机溶剂中,引起丝素变性和结构β化而形成乳白色结晶性丝素微粒,同时酶被包埋和固定在微粒中。经过滤或离心去除有机溶剂后,制成结晶性的固定化酶丝素纳米颗粒。这种固定化酶平均粒度35~125nm,活性回收率高达70%、热稳定性大大提高、不易被体外或体内的蛋白酶分解,能大大降低或消除酶的免疫原性。这种固定化酶丝素纳米颗粒在药物缓释系统、工业酶反应器、食品添加剂和高级化妆品等方面有广泛的应用前景。The invention discloses a silk fibroin nanoparticle for producing immobilized enzymes by using silk fibroin and a preparation method thereof, belonging to the field of biotechnology enzyme engineering. The technical scheme is: after fully mixing the enzyme with the water-soluble regenerated silk fibroin solution, inject it into the excess water-soluble organic solvent stirred at a high speed, causing the denaturation and β-transformation of the silk fibroin to form milky white crystalline silk fibroin particles, and at the same time, the enzyme Entrapped and immobilized in microparticles. After filtering or centrifuging to remove the organic solvent, the crystalline immobilized enzyme silk fibroin nanoparticles are prepared. The average particle size of the immobilized enzyme is 35-125nm, the activity recovery rate is as high as 70%, the thermal stability is greatly improved, it is not easy to be decomposed by protease in vitro or in vivo, and the immunogenicity of the enzyme can be greatly reduced or eliminated. The immobilized enzyme silk fibroin nanoparticles have broad application prospects in drug sustained release systems, industrial enzyme reactors, food additives and advanced cosmetics.
Description
技术领域 technical field
本发明公开了一种固定化酶的载体及其制备方法,特别涉及一种用蚕丝丝素制造固定化酶的丝素纳米颗粒及其制备方法,属于生物技术酶工程领域,也属于纳米技术领域和高分子化学技术领域。The invention discloses a carrier for immobilized enzymes and a preparation method thereof, in particular to a silk fibroin nanoparticle for immobilized enzymes produced by silk fibroin and a preparation method thereof, which belongs to the field of biotechnology enzyme engineering and also belongs to the field of nanotechnology and polymer chemistry technology.
背景技术 Background technique
将酶或药物以微粒、微囊、脂质体、白蛋白、红细胞载体等形式引入体内,可以延长酶或药物的半衰期,使之缓慢释放,提高酶或药物对遗传性缺酶症、代谢紊乱症、肿瘤以及心血管病等的治疗功效。以天然生物材料作为酶固定化载体或作为药物的缓释载体的研究颇多,是因为它有安全、稳定、生物相容性并能在体内代谢等优点。家蚕生产的丝素蛋白是一种天然的高分子聚合物,分子量高达37万。由于这种蛋白质对人体无毒、无害、无免疫性,长期以来一直用作医用手术缝合线。近年来,对丝素进行在人工皮肤、化妆品和营养食品的原料或作为固定化细胞、酶和抗体的载体等方面的开发利用受到关注。特别是以丝素蛋白为固定化酶载体的研究在过去的二十多年中尤其活跃,已有许许多多实验充分证实丝素蛋白是一种优良的固定化酶生物材料。Introducing enzymes or drugs into the body in the form of particles, microcapsules, liposomes, albumin, red blood cell carriers, etc. can prolong the half-life of enzymes or drugs, make them release slowly, and improve the effect of enzymes or drugs on hereditary enzyme deficiency and metabolic disorders. Therapeutic efficacy of diseases, tumors and cardiovascular diseases. There are many studies on the use of natural biological materials as enzyme immobilization carriers or drug slow-release carriers because of their safety, stability, biocompatibility and ability to metabolize in vivo. The silk fibroin produced by the silkworm is a natural polymer with a molecular weight of 370,000. Since this protein is non-toxic, harmless, and non-immune to the human body, it has long been used as a medical surgical suture. In recent years, the development and utilization of silk fibroin as a raw material for artificial skin, cosmetics and nutraceuticals or as a carrier for immobilized cells, enzymes and antibodies has attracted attention. In particular, the research on silk fibroin as an immobilized enzyme carrier has been particularly active in the past two decades, and many experiments have fully confirmed that silk fibroin is an excellent biomaterial for immobilized enzymes.
以丝素蛋白作为酶固定化载体具有其它高分子材料所没有的优点,酶固定化的原理是建立在丝素蛋白从可溶性的无规线圈和α-螺旋的结构转变成不溶性的反向平行β-折叠结构,与此同时也完成了酶的固定化。用丝素作为固定化酶载体有多种形态如丝素膜、丝素纤维、丝素粉末或丝素凝胶。其中丝素粉末的制备及其应用研究十分活跃,已有大量的专利报道,主要是通过物理或化学方法诱导丝素蛋白凝聚如盐析、超声波、充气、高速搅拌,等电点凝聚、电析或先成膜后机械粉碎或直接对丝纤维进行多次机械粉碎等方法,制成1~100微米不等的超细丝素粉末,在化妆品、营养食品、添加剂、高吸水材料和涂料等方面有广泛的应用前景。然而,这些方法或加工环境大多不适合制备活性高、性能稳定的固定化酶。公开号为CN1560136的中国发明专利(国际专利WO2005085327 A1)“丝素纳米颗粒的制造方法”中,公开了一种将水溶性再生丝素溶液直接与过量的能与水混溶的有机溶剂混合制成丝素纳米颗粒的制备方法,但其中有些有机溶剂会引起酶的失活而不适宜制备固定化酶。Using silk fibroin as an enzyme immobilization carrier has advantages that other polymer materials do not have. The principle of enzyme immobilization is based on the transformation of silk fibroin from a soluble random coil and α-helix structure into an insoluble antiparallel β -Folding structure, at the same time immobilization of the enzyme is also completed. There are various forms of silk fibroin as the immobilized enzyme carrier, such as silk film, silk fiber, silk powder or silk gel. Among them, the preparation and application research of silk fibroin powder is very active, and there have been a large number of patent reports, mainly through physical or chemical methods to induce silk fibroin protein aggregation, such as salting out, ultrasonic, aeration, high-speed stirring, isoelectric point aggregation, electrolysis, etc. Or mechanical pulverization after film formation or direct mechanical pulverization of silk fibers many times to make superfine silk fibroin powder ranging from 1 to 100 microns, which is used in cosmetics, nutritional foods, additives, super absorbent materials and coatings, etc. It has broad application prospects. However, most of these methods or processing environments are not suitable for the preparation of immobilized enzymes with high activity and stable performance. Publication number is CN1560136 Chinese invention patent (international patent WO2005085327 A1) "manufacturing method of silk fibroin nanoparticles", discloses a water-soluble regenerated silk fibroin solution directly mixed with excess water-miscible organic solvent A method for preparing fibroin nanoparticles, but some organic solvents may cause enzyme inactivation and are not suitable for preparing immobilized enzymes.
丝素粉末用于酶和活性物质的固定化研究起源于上个世纪80年代初,主要是利用盐析、高速搅动、蛋白冻融以及加入少量有机溶剂或调节等电点等方法使丝素蛋白沉淀、凝聚或变性,然后进行干燥和粉碎而制成固定化酶。水溶性丝素和酶混合液,用无机盐或无机盐与有机盐混合物进行盐析使之沉淀制备固定化酶(日本专利,特开昭JP56-15687;特开昭JP60-155125,国际专利,WO8503230;特开昭JP62-151180);或者将丝素和酶混合液先调至酸性或碱性,再经盐析、冲洗、干燥后制成粉末状的固定化酶(日本专利,特开昭JP56-051983,特开昭JP56-39783)。在丝素和酶混合液中加入少量甲醇等有机溶剂直接诱导丝素凝聚,或者先将丝素酶混合液调节到丝素等电点附近,再加入少量有机溶剂诱导丝素凝聚,然后将凝聚物冲洗、干燥和粉碎后制成固定化α-淀粉和蔗糖酶(日本专利,特开昭JP1-313530),或者制成固定化碱性或中性蛋白酶(日本专利,特开昭JP56-18590)。通过高速搅动使丝素凝聚或充气引起丝素和酶混合液产生大量泡沫而制成固定化酶(日本专利,特开昭JP60-227679,特开昭JP61-187790)。将丝素和酶的混合液先冻结后融化使丝素变性而制成固定化碱性磷酸酶(日本专利,特开昭JP01-120287)。还有利用盐析法先制成丝素粉末,然后应用交联剂将丝素粉末与糖化酶交联制成固定化酶粉末[《蚕业科学》,25(2):113-119,1999]。除此以外,有关以丝素粉末为载体的固定化酶研究在国内外没有更多的报道。究其原因主要是由于上述这些方法制备的丝素粉末结晶性差、稳定性差、比表面小、固定化酶活性低下。而且在制备过程中形成的凝聚物或沉淀物都需要干燥和反复粉碎等加工工艺,由此制备的丝素粉末粒径大,形状各异,都在微米级以上。The immobilization research of silk fibroin powder for enzymes and active substances originated in the early 1980s, mainly using methods such as salting out, high-speed stirring, freezing and thawing of protein, adding a small amount of organic solvent or adjusting the isoelectric point to make silk fibroin Precipitation, aggregation or denaturation, followed by drying and crushing to make immobilized enzymes. Water-soluble silk fibroin and enzyme mixed solution are salted out with inorganic salt or inorganic salt and organic salt mixture to make it precipitate to prepare immobilized enzyme (Japanese patent, JP56-15687; JP60-155125, international patent, WO8503230; JP62-151180 of JP62-151180); or the silk fibroin and enzyme mixed solution are first adjusted to acidity or alkaline, and then powdered immobilized enzyme is made after salting out, washing and drying (Japanese patent, JP62-151180). JP56-051983, JP56-39783). Add a small amount of organic solvents such as methanol to the silk fibroin and enzyme mixture to directly induce silk fibroin aggregation, or first adjust the silk fibroin enzyme mixture to the vicinity of the isoelectric point of silk fibroin, then add a small amount of organic solvent to induce silk fibroin aggregation, and then agglomerate Make immobilized α-amylase and sucrase (Japanese patent, JP1-313530 of Japanese Patent, JP1-313530) after washing, drying and crushing of the thing, or make immobilized alkaline or neutral protease (Japanese patent, JP56-18590 of JP56-18590 of JP) ). The silk fibroin is agglomerated or aerated by high-speed agitation to cause a large amount of foam to be produced from the silk fibroin and enzyme mixture (Japanese Patent, JP60-227679, JP61-187790). The mixture of silk fibroin and enzyme is first frozen and then melted to denature the silk fibroin to make immobilized alkaline phosphatase (Japanese patent, JP01-120287). There is also the use of salting-out method to make silk fibroin powder, and then use cross-linking agent to cross-link silk fibroin powder and glucoamylase to make immobilized enzyme powder ["Sericulture Science", 25 (2): 113-119, 1999 ]. In addition, there are no more reports at home and abroad on the study of immobilized enzymes using silk fibroin powder as a carrier. Trace it to its cause mainly because the silk fibroin powder prepared by above-mentioned these methods has poor crystallinity, poor stability, small specific surface area and low immobilized enzyme activity. Moreover, the aggregates or precipitates formed during the preparation process require drying and repeated crushing and other processing techniques. The silk fibroin powder thus prepared has a large particle size and various shapes, all of which are above the micron level.
发明内容 Contents of the invention
本发明的目的在于克服现有技术存在的不足,提供一种具有良好的生物相容性、酶活性回收率高、生产工艺简单的固定化酶的丝素纳米颗粒及其制备方法。The purpose of the present invention is to overcome the deficiencies in the prior art, and provide a silk fibroin nanoparticle with good biocompatibility, high recovery rate of enzyme activity and simple production process for immobilizing enzymes and a preparation method thereof.
本发明采用的技术方案是:提供一种固定化酶的丝素纳米颗粒,它以丝素蛋白为核心,酶被包埋并固定于微粒表层中,平均粒度为35~125nm,不溶于水;所述的丝素蛋白呈β-折叠结构,结晶度为20%以上。The technical scheme adopted in the present invention is: provide a silk fibroin nanoparticle with immobilized enzyme, which takes silk fibroin as the core, the enzyme is embedded and fixed in the surface layer of the particle, the average particle size is 35-125nm, and it is insoluble in water; The silk fibroin has a β-sheet structure and a crystallinity of more than 20%.
制备上述固定化酶的丝素纳米颗粒的方法,将水溶性丝素溶液与酶混合均匀,再将丝素酶混合液注入到快速搅动的水溶性有机溶剂中,其丝素酶液与有机溶剂的混合体积比为1∶2.3以上,形成乳白色丝素蛋白为核心,表层包埋并固定酶的球形微粒分散在有机溶剂体系中,得到固定化酶的丝素纳米颗粒混合液或悬浮液,再去除其中的有机溶剂,得到固定化酶的丝素纳米颗粒。The method for preparing the above-mentioned silk fibroin nanoparticles with immobilized enzymes is to mix the water-soluble silk fibroin solution and the enzyme evenly, and then inject the silk enzyme mixed solution into a rapidly stirred water-soluble organic solvent, and the silk fibroin enzyme liquid and the organic solvent The mixed volume ratio is more than 1: 2.3, the milky white silk fibroin is formed as the core, and the surface layer embeds and immobilizes the spherical particles of the enzyme dispersed in the organic solvent system to obtain the silk fibroin nanoparticle mixture or suspension of the immobilized enzyme, and then The organic solvent is removed to obtain the silk fibroin nanoparticles with immobilized enzyme.
上述技术方案中所述的水溶性丝素包括由家蚕丝或野蚕丝,或者由基因工程生产的类蚕丝蛋白纯化而成;所述的丝素溶液浓度为0.1~20%。The water-soluble silk fibroin described in the above technical solution is purified from domestic silkworm silk or wild silkworm silk, or silk-like protein produced by genetic engineering; the concentration of the silk fibroin solution is 0.1-20%.
上述技术方案中所述的与丝素液混合的酶指氧化还原酶、水解酶和异构酶当中的一种或者二种以上的混合酶。The enzyme mixed with the silk fibroin solution described in the above technical solution refers to one or more mixed enzymes among oxidoreductase, hydrolase and isomerase.
在上述丝素酶液注入有机溶剂时,搅拌速度在50转/分钟以上。When the above-mentioned silk fibroin enzyme liquid is injected into the organic solvent, the stirring speed is above 50 rpm.
所述的水溶性有机溶剂为乙醇或丙酮。Described water-miscible organic solvent is ethanol or acetone.
上述固定化酶的丝素纳米颗粒的制造方法,其制备工作环境温度在10~45℃,最好在25~37℃之间。For the above-mentioned manufacturing method of silk fibroin nanoparticles with immobilized enzymes, the working environment temperature for the preparation is 10-45°C, preferably 25-37°C.
对固定化酶丝素纳米颗粒的有机溶剂混合液或悬浮液进行反复离心脱水处理,或进行反复过滤、清洗处理,直至完全去除有机溶剂。The organic solvent mixture or suspension of immobilized enzyme silk fibroin nanoparticles is repeatedly centrifuged and dehydrated, or repeatedly filtered and washed until the organic solvent is completely removed.
对获得的丝素纳米颗粒加入纯水或水溶液后进行超声处理1~10min,制成固定化酶的纳米丝素液。The obtained silk fibroin nanoparticles are added into pure water or an aqueous solution, and then ultrasonically treated for 1 to 10 minutes to prepare a nano silk fibroin solution with immobilized enzymes.
对获得的固定化酶的丝素纳米颗粒的有机溶剂混合液或悬浮液进行真空冷冻干燥,制成固定化酶纳米丝素粉末。The obtained organic solvent mixture or suspension of silk fibroin nanoparticles with immobilized enzymes is subjected to vacuum freeze-drying to prepare nano silk fibroin powder with immobilized enzymes.
众所周知,水溶性有机溶剂是一种最常用的蛋白变性剂,当具有生物活性的蛋白酶遇到高浓度有机溶剂时会变性失活。丝素也是一种高分子蛋白,当将丝素纤维制成再生的水溶性丝素蛋白时,易受到物理或化学因素影响而发生蛋白变性,尤其是遇到有机溶剂时更易发生结构变化而凝聚沉淀。在以往研究中,是将少量有机溶剂加入到丝素与酶的混合溶液中促使丝素蛋白凝聚或沉淀,使酶包埋在丝素沉淀物中,然后再干燥和粉碎制成固定化酶。本发明利用蚕丝蛋白结构易受改变和水溶性有机溶剂易引起蛋白变性的二大特性,将少量的丝素与酶的混合溶液注入到高速搅动的超大量的纯有机溶剂中,促使丝素蛋白快速分散与变性,水溶性丝素直接从α-螺旋和无规线圈转变成β-折叠结构,在形成结晶性丝素颗粒的同时,酶被包埋和固定化,从而获得纳米级的、性能稳定的、不溶于水的固定化酶丝素纳米颗粒。本发明还发现固定化酶效果较好的是乙醇和丙酮,因此,优选的技术方案是,有机溶剂为乙醇或丙酮。As we all know, water-soluble organic solvents are the most commonly used protein denaturants. When biologically active proteases encounter high concentrations of organic solvents, they will be denatured and inactivated. Silk fibroin is also a high-molecular protein. When the silk fibroin fiber is made into regenerated water-soluble silk fibroin, it is susceptible to protein denaturation due to physical or chemical factors, especially when encountering organic solvents, it is more likely to undergo structural changes and coagulate. precipitation. In previous studies, a small amount of organic solvent was added to the mixed solution of silk fibroin and enzyme to promote the aggregation or precipitation of silk fibroin, so that the enzyme was embedded in the silk fibroin precipitate, and then dried and pulverized to make immobilized enzyme. The present invention utilizes the two characteristics that the structure of silk protein is easy to be changed and water-soluble organic solvents are easy to cause protein denaturation, and a small amount of mixed solution of silk fibroin and enzyme is injected into a large amount of pure organic solvent stirred at high speed to promote silk fibroin Rapid dispersion and denaturation, water-soluble silk fibroin directly transforms from α-helix and random coil to β-sheet structure, while forming crystalline silk fibroin particles, enzymes are embedded and immobilized, thereby obtaining nanoscale, high performance Stable, water-insoluble immobilized enzyme silk fibroin nanoparticles. The present invention also finds that ethanol and acetone are better for the immobilized enzyme effect, therefore, the preferred technical solution is that the organic solvent is ethanol or acetone.
与现有技术相比,本发明具有以下优点:Compared with the prior art, the present invention has the following advantages:
由于丝素与过量的水溶性有机溶剂混合后,可溶性的丝素蛋白从无规线圈和α-螺旋结构瞬间转化为不溶性的反向平行β-折叠结构。因此,得到的固定化酶丝素颗粒平均80nm左右,酶活性回收率高达60%,电子显微镜观察呈球形,结晶度达20%以上、性能稳定、不易被蛋白酶分解,具有强力阻挡紫外辐射的功能,在体内能大大降低或消除酶的免疫原性,延长酶半衰期。After the silk fibroin is mixed with an excess of water-soluble organic solvent, the soluble silk fibroin instantly transforms from the random coil and α-helix structure into the insoluble antiparallel β-sheet structure. Therefore, the average size of the obtained immobilized silk fibroin particles is about 80nm, the recovery rate of the enzyme activity is as high as 60%, the electron microscope observation shows a spherical shape, the crystallinity is over 20%, the performance is stable, it is not easy to be decomposed by protease, and it has a strong function of blocking ultraviolet radiation , can greatly reduce or eliminate the immunogenicity of enzymes in vivo, and prolong the half-life of enzymes.
本发明技术方案所提供的固定化酶的丝素纳米颗粒稳定性好,无论是颗粒悬浮液还是冻干粉状态,可长期放在室温下,而酶活性不会受到任何影响,不需象纯酶那样须在4℃或4℃以下保存;制造的冻干粉状态的固定化酶丝素纳米颗粒能抗高温,在90~100℃烘干1小时也不丢失酶活性。The silk fibroin nanoparticles of the immobilized enzyme provided by the technical scheme of the present invention have good stability, whether it is in the state of particle suspension or freeze-dried powder, it can be placed at room temperature for a long time, and the enzyme activity will not be affected in any way. Enzymes must be stored at or below 4°C; the immobilized enzyme silk fibroin nanoparticles in the state of freeze-dried powder produced can resist high temperature, and the enzyme activity will not be lost after drying at 90-100°C for 1 hour.
按本发明技术方案,由于在制备过程中不使用有毒的化学试剂,因此,得到的固定化酶的纳米丝素对人体无毒、无害,且具有良好的生物相容性,是一种绿色环保产品。所使用的乙醇、丙酮等有机溶剂与丝素酶溶液混合后,生成乳白色固定化酶丝素纳米颗粒悬浮液,经过滤或离心分离,其废弃的过滤液或上清液可回收重蒸;或者经真空冷冻干燥后升华的有机溶剂水溶液也同样可回收重蒸,循环使用。还由于产品制备工艺简单,成本低、效益高,因此,具有广阔的市场前景。According to the technical scheme of the present invention, since no toxic chemical reagents are used in the preparation process, the obtained nano-silk fibroin with immobilized enzymes is non-toxic and harmless to the human body, and has good biocompatibility. It is a green Environmentally friendly products. After the organic solvents such as ethanol and acetone used are mixed with the silk fibroin enzyme solution, a milky white immobilized enzyme silk fibroin nanoparticle suspension is generated, which is filtered or centrifuged, and the discarded filtrate or supernatant can be recycled and re-distilled; or The sublimated organic solvent aqueous solution after vacuum freeze-drying can also be recovered and re-distilled for recycling. Also because the preparation process of the product is simple, the cost is low, and the benefit is high, it has broad market prospects.
附图说明 Description of drawings
图1是按本发明实施例1制造方法得到的固定化葡萄糖氧化酶丝素纳米颗粒的荧光发射光谱;Fig. 1 is the fluorescence emission spectrum of the immobilized glucose oxidase silk fibroin nanoparticle obtained by the manufacturing method of Example 1 of the present invention;
图2是按本发明实施例1制造方法得到的固定化葡萄糖氧化酶丝素纳米颗粒的红外吸收光谱;Fig. 2 is the infrared absorption spectrum of the immobilized glucose oxidase silk fibroin nanoparticle obtained by the manufacturing method of Example 1 of the present invention;
图3是按本发明实施例1制造方法得到的固定化葡萄糖氧化酶丝素纳米颗粒的X-射线衍射图谱;Fig. 3 is the X-ray diffraction pattern of the immobilized glucose oxidase silk fibroin nanoparticle obtained by the manufacturing method of Example 1 of the present invention;
图4是按本发明实施例1制造方法得到的固定化葡萄糖氧化酶丝素纳米颗粒的粒度分布图。Fig. 4 is a particle size distribution diagram of the immobilized glucose oxidase silk fibroin nanoparticles obtained according to the manufacturing method of Example 1 of the present invention.
具体实施方式 Detailed ways
下面结合实施例对本发明作进一步的阐述。The present invention will be further elaborated below in conjunction with embodiment.
实施例一:Embodiment one:
取在蚕桑、种茧生产和缫丝、纺织生产中的种茧、茧衣、废丝或废绸布等清洗后,加入30倍量的0.5%碳酸钠水溶液或其它碱性溶液或者加入表面活性剂等进行煮沸1小时,再换液1次,再煮沸1小时,确保将丝胶全部脱除。脱除丝胶的丝素纤维经反复用水冲洗后烘干备用。After cleaning the seed cocoons, cocoon clothes, waste silk or waste silk cloth in sericulture, seed cocoon production, silk reeling, and textile production, add 30 times the amount of 0.5% sodium carbonate aqueous solution or other alkaline solutions or add surface active Boil for 1 hour, change the liquid once more, and boil for 1 hour to ensure that all the sericin is removed. The silk fiber from which the sericin has been removed is washed with water repeatedly and then dried for use.
取上述脱除丝胶的丝素纤维与5~20倍量(W/V)的8~9M溴化锂水溶液或者是溴化锂甲醇水三元混合溶剂混合,在40℃以上溶解2~40小时;或者是将丝素纤维与5~20倍量的氯化钙/乙醇/水三元混合溶剂(摩尔比1∶2∶8)混合,在50℃以上溶解1~5小时;或者是将上述丝素纤维溶解在其它浓盐溶液或有机溶剂中。将上述获得的各种丝素溶解液进行透析、脱盐、纯化,制成浓度为0.5~15%的水溶性丝素溶液,最好是浓缩或稀释成1.5~3.5%水溶性丝素溶液。Take the above-mentioned silk fiber from which sericin has been removed and mix it with 5-20 times the amount (W/V) of 8-9M lithium bromide aqueous solution or lithium bromide-methanol-water ternary mixed solvent, and dissolve at 40°C for 2-40 hours; or Mix the silk fiber with 5-20 times the amount of calcium chloride/ethanol/water ternary mixed solvent (molar ratio 1:2:8), and dissolve it at 50°C for 1-5 hours; or mix the above-mentioned silk fiber Dissolved in other concentrated salt solutions or organic solvents. Dialyze, desalt, and purify the various silk fibroin solutions obtained above to prepare a water-soluble silk fibroin solution with a concentration of 0.5-15%, preferably concentrated or diluted to a water-soluble silk fibroin solution with a concentration of 1.5-3.5%.
取上述浓度为1.5~3.5%水溶性丝素溶液,加入占丝素总量0.0001~1%的葡萄糖氧化酶,通过搅拌装置使丝素酶混合溶液搅动,在10~45℃的环境条件下,最好是在25~37℃环境条件下,快速加入过量的丙酮(最终体积70%以上)中,使丝素蛋白快速变性成超微颗粒悬浮在有机溶剂中,经滤纸过滤,将过滤后的固定化酶丝素湿粉末置缓冲溶液中,经超声处理后成固定化葡萄糖氧化酶的丝素纳米颗粒悬浮液,可直接用于酶活性测定;或者将过滤后的固定化酶丝素湿粉末置-20℃冻结,最后,进行真空冷冻干燥,得到粉末状的固定化葡萄糖氧化酶丝素纳米颗粒。Take the above water-soluble silk fibroin solution with a concentration of 1.5-3.5%, add glucose oxidase which accounts for 0.0001-1% of the total amount of silk fibroin, stir the silk fibroinase mixed solution through a stirring device, and under the environmental conditions of 10-45°C, It is best to quickly add excess acetone (more than 70% of the final volume) under the environmental conditions of 25-37°C, so that the silk fibroin can be rapidly denatured into ultrafine particles, suspended in an organic solvent, filtered through filter paper, and the filtered The immobilized enzyme silk fibroin wet powder is placed in a buffer solution, and after ultrasonic treatment, the silk fibroin nanoparticle suspension of immobilized glucose oxidase can be directly used for the determination of enzyme activity; or the filtered immobilized enzyme silk fibroin wet powder Freezing at -20°C, and finally vacuum freeze-drying to obtain powdered immobilized glucose oxidase silk fibroin nanoparticles.
采用以前报道的方法(Kawahara Y:Journal of Sericulture Science ofJapan,62(4),272-275,1993)略加改进后测定葡萄糖氧化酶活性。具体操作步骤如下:在测定管、标准管和空白管中分别加入2.4ml染色缓冲液、0.5mL 10%底物葡萄糖溶液和0.1ml过氧化物酶溶液,摇匀,置37℃恒温2~5min后最后加入游离酶开始反应,以空白管为对照,500nm波长处测定5分钟内反应的吸光度变化值,然后除5得到每分钟将1.0mmol/L β-D-葡萄糖氧化为D-葡萄糖酸和H2O2所增加的吸光度值。当测定固定化酶时,因丝素颗粒悬浮在比色皿中边反应边测定会挡住紫外光线的透过,干扰测定,所以,自制固定化酶反应器,当反应5min后,立即抽滤出反应液测定吸光度值。1个单位葡萄糖氧化酶活性定义为在37℃,pH5.5磷酸钠缓冲液条件下每分钟催化1.0mmol/L β-D-葡萄糖氧化为D-葡萄糖酸和H2O2所产生的吸光度变化值。表中数值均为5次重复测定的平均值。从表中可知,固定化酶的活性回收率在24.5~72.9%之间。Glucose oxidase activity was measured by a slightly modified method previously reported (Kawahara Y: Journal of Sericulture Science of Japan, 62(4), 272-275, 1993). The specific operation steps are as follows: Add 2.4ml of staining buffer, 0.5mL of 10% substrate glucose solution and 0.1ml of peroxidase solution to the measurement tube, standard tube and blank tube respectively, shake well, and keep the temperature at 37°C for 2-5min Finally, add free enzyme to start the reaction, take the blank tube as a contrast, measure the absorbance change value of the reaction within 5 minutes at a wavelength of 500nm, and then divide by 5 to obtain the oxidation of 1.0mmol/L β-D-glucose into D-gluconic acid and Absorbance value increased by H2O2 . When measuring the immobilized enzyme, since silk fibroin particles are suspended in the cuvette while reacting, the measurement will block the transmission of ultraviolet light and interfere with the measurement. Therefore, a self-made immobilized enzyme reactor is made, and after 5 minutes of reaction, it is immediately filtered out The absorbance value of the reaction solution was measured. One unit of glucose oxidase activity is defined as the change in absorbance produced by catalyzing the oxidation of 1.0mmol/L β-D-glucose to D-gluconic acid and H 2 O 2 per minute under the condition of 37°C and pH 5.5 sodium phosphate buffer value. The values in the table are the average value of 5 repeated determinations. It can be seen from the table that the recovery rate of the activity of the immobilized enzyme is between 24.5% and 72.9%.
表1:固定化葡萄糖氧化酶活性回收率Table 1: Recovery rate of immobilized glucose oxidase activity
参见附图1,固定化葡萄糖氧化酶丝素纳米颗粒水中悬浮液和含酶水溶性丝素溶液在日立荧光分光光度计(F-4500 FL Spectrophotometer)上测度的荧光发射光谱。测定条件:激发波长290nm,激发狭缝10.0nm,发射狭缝5.0nm,扫描速度240nm/min,灵敏度0.5s。从图中可以发现丝素纳米化以后,荧光发射光谱发生蓝移10nm左右,表明丝素分子从无规线圈和α-缓螺旋转变成β-折叠的构造。Referring to accompanying drawing 1, the fluorescence emission spectrum of immobilized glucose oxidase silk fibroin nanoparticle suspension in water and water-soluble silk fibroin solution containing enzyme is measured on Hitachi fluorescence spectrophotometer (F-4500 FL Spectrophotometer). Measurement conditions: excitation wavelength 290nm, excitation slit 10.0nm, emission slit 5.0nm, scanning speed 240nm/min, sensitivity 0.5s. It can be seen from the figure that after the silk fibroin is nano-sized, the fluorescence emission spectrum has a blue shift of about 10nm, indicating that the silk fibroin molecule has transformed from a random coil and an α-slow helix to a β-sheet structure.
参见附图2,固定化葡萄糖氧化酶丝素纳米颗粒冻干粉和含酶水溶性丝素溶液冻干粉用少许KBr压片制样,在Magna 550红外分光光度计(NicoletInstrument Corp.USA)上进行测定,扫描范围为4000~200cm-1。图中含酶水溶性丝素的红外吸收光谱显示无规卷曲和α-缓螺旋或称曲柄形结构(Silk I)特征,当丝素纳米化后其吸收带发生位移,出现了反向平行β-折叠(Silk II)的构造。Referring to accompanying drawing 2, immobilized glucose oxidase silk fibroin nanoparticle lyophilized powder and enzyme-containing water-soluble silk fibroin solution lyophilized powder are prepared with a little KBr tablet, on Magna 550 infrared spectrophotometer (NicoletInstrument Corp.USA) For measurement, the scanning range is 4000-200 cm -1 . The infrared absorption spectrum of enzyme-containing water-soluble silk fibroin in the figure shows the characteristics of random coil and α-slow helix or crank-shaped structure (Silk I). When the silk fibroin is nano-sized, its absorption band shifts, and antiparallel β appears. - Construction of the fold (Silk II).
参见附图3,在MERCURY CCD-AFC8型CCD单晶X-射线衍射仪(日本理学电机株式会社)进行丝素样品分析,管电压为4.0kV,管电流为35mA,扫描速度2°/min,Ni滤波。从2θ=5°~45°进行扫描,得到固定化葡萄糖氧化酶丝素纳米颗粒冻干粉和含酶水溶性丝素溶液冻干粉的X-射线衍射图谱。含酶水溶性丝素冻干粉可确认为完全无定形结构,而在丙酮中丝素纳米化后,丝素分子构象由Silk I向Silk II转化,成为结晶性的固定化酶丝素纳米颗粒。Referring to accompanying drawing 3, carry out silk fibroin sample analysis in MERCURY CCD-AFC8 type CCD single crystal X-ray diffractometer (Rigaku Electric Co., Ltd.), tube voltage is 4.0kV, tube current is 35mA, scanning speed 2 °/min, Ni filter. Scan from 2θ=5° to 45°, and obtain the X-ray diffraction patterns of the freeze-dried powder of the immobilized glucose oxidase silk fibroin nanoparticles and the freeze-dried powder of the enzyme-containing water-soluble silk fibroin solution. The enzyme-containing water-soluble silk fibroin freeze-dried powder can be confirmed as a completely amorphous structure, and after the silk fibroin is nano-sized in acetone, the molecular conformation of silk fibroin transforms from Silk I to Silk II, and becomes crystalline immobilized enzyme silk fibroin nanoparticles .
参见附图4,固定化葡萄糖氧化酶丝素纳米颗粒用水稀释,超声处理后直接放入样品杯,在Zetasizer 3000HSa激光粒度仪(Malvern Instruments Ltd,Malvern UK)上测定颗粒粒度分布情况。从图可知,固定化酶的丝素纳米颗粒粒度分布在35~125nm之间。Referring to accompanying drawing 4, the immobilized glucose oxidase silk fibroin nanoparticle is diluted with water, puts directly into the sample cup after sonication, and measures particle size distribution situation on Zetasizer 3000HSa laser particle size analyzer (Malvern Instruments Ltd, Malvern UK). It can be seen from the figure that the particle size distribution of silk fibroin nanoparticles immobilized with enzyme is between 35 and 125 nm.
实施例二:Embodiment two:
与实施例一制备方法相同,将1.5~3.5%的水溶性丝素溶液与超氧物歧化酶混合后,加入快速搅动的过量丙酮(最终体积70%以上)中,其余制备步骤全部相同。用这种丙酮处理方法分别制备得到固定化超氧物歧化酶丝素纳米颗粒悬浮液或冻干粉,其活性测定方法以及固定化酶的活性回收率见表2。表中数值均为5次重复测定的平均值。The preparation method is the same as that in Example 1. After mixing 1.5-3.5% water-soluble silk fibroin solution with superoxide dismutase, add it to excess acetone (final volume above 70%) that is stirred rapidly, and the rest of the preparation steps are the same. The acetone treatment method was used to prepare immobilized superoxide dismutase silk fibroin nanoparticle suspension or freeze-dried powder. The activity determination method and the activity recovery rate of the immobilized enzyme are shown in Table 2. The values in the table are the average value of 5 repeated determinations.
本实验使用超氧物歧化酶(SOD)测定试剂盒(南京建成生物工程研究所一分所生产)测定溶液酶或固定化酶的活性。其测定方法是通过黄嘌呤及黄嘌呤氧化酶反应系统产生O2 -,后者氧化羟胺形成亚硝酸盐,在显色剂作用下呈现紫红色,用日立U3000紫外可见分光光度计测定其吸光度。当被测样品中含有SOD时,则对超氧阴离子自由基有专一性的抑制作用,使形成的亚硝酸盐减少,比色时测定管的吸光度值低于对照管的吸光度值,通过公式计算被测样品SOD活力(NU/ml,以亚硝酸盐单位表示)。表中固定化酶活性回收率是以牛血超氧化物歧化酶(上海东方丽珠生物化学制品有限公司生产)活性为100%计算的。结果表明固定化超氧物歧化酶的活性回收率在25~79.4%之间。In this experiment, the superoxide dismutase (SOD) assay kit (produced by Nanjing Jiancheng Bioengineering Institute Branch 1) was used to measure the activity of solution enzyme or immobilized enzyme. Its determination method is to generate O 2 - through the reaction system of xanthine and xanthine oxidase, and the latter oxidizes hydroxylamine to form nitrite, which turns purple under the action of chromogen, and measures its absorbance with Hitachi U3000 UV-Vis spectrophotometer. When the tested sample contains SOD, it has a specific inhibitory effect on superoxide anion free radicals, reducing the formed nitrite, and the absorbance value of the measuring tube is lower than that of the control tube during colorimetry, through the formula Calculate the SOD activity of the tested sample (NU/ml, expressed in nitrite units). The recovery rate of immobilized enzyme activity in the table is calculated based on the activity of bovine blood superoxide dismutase (produced by Shanghai Dongfang Livzon Biochemical Products Co., Ltd.) as 100%. The results showed that the activity recovery rate of immobilized superoxide dismutase was between 25% and 79.4%.
表2.固定化超氧物歧化酶的活性回收率Table 2. Activity recovery of immobilized superoxide dismutase
实施例三:Embodiment three:
与实施例一制备方法相同,将1.5~3.5%的水溶性丝素溶液与L-天冬酰胺酶混合后,加入快速搅动的过量丙酮(最终体积70%以上)中,其余制备步骤全部相同。用这种丙酮处理方法分别制备得到固定化L-天冬酰胺酶丝素纳米颗粒悬浮液或冻干粉,其活性测定方法以及固定化酶的活性回收率见表3。表中数值均为5次重复测定的平均值。The preparation method is the same as that in Example 1. After mixing 1.5-3.5% water-soluble silk fibroin solution with L-asparaginase, add it to excess acetone (final volume above 70%) that is stirred rapidly, and the rest of the preparation steps are the same. The immobilized L-asparaginase silk fibroin nanoparticle suspension or freeze-dried powder were respectively prepared by this acetone treatment method, and the activity determination method and the activity recovery rate of the immobilized enzyme are shown in Table 3. The values in the table are the average value of 5 repeated determinations.
L-天冬酰胺酶活性测定方法(Mashburn,L.T.,Wriston,J.C.,jr.:Tumorinhibitory effect of L-Asparaginase.Biochen.Biophys.Res.Comm.12:50,1963):用移液管向数支离心管滴入0.2ml Tris-HCl缓冲溶液(pH8.6)和1.7ml底物溶液,置于水浴中调温至37℃。加0.10ml游离酶溶液或固定化酶后精确保温10min。加0.10ml三氯醋酸溶液,反应终止。离心分离后取出0.50ml上清液滴入7.0ml蒸馏水中,再加1.0ml奈氏试剂。室温下静置10min后用分光光度计(480nm处)以空白管为对照测定吸光度。当一系列不同浓度的游离酶经上述同样方法测定后,计算游离酶浓度与吸光度关系,作出校正曲线获得线性方程。然后,根据这个线性方程(y=0.4286x+0.0555)计算固定化酶样品中实测到的酶活性,最后将样品中酶的加入总量除以样品中实测酶活性得出固定化酶活性回收率,结果见表3。从表中可知,固定化L-天冬酰胺酶活性回收率在13%以上,最高可达76%。L-asparaginase activity assay method (Mashburn, L.T., Wriston, J.C., jr.: Tumorinhibitory effect of L-Asparaginase. Biochen. Biophys. Res. Comm. 12: 50, 1963): use pipette to several Add 0.2ml Tris-HCl buffer solution (pH8.6) and 1.7ml substrate solution dropwise into the centrifuge tube, place in a water bath and adjust the temperature to 37°C. Add 0.10ml of free enzyme solution or immobilized enzyme and then accurately incubate for 10min. Add 0.10ml trichloroacetic acid solution to terminate the reaction. After centrifugation, take out 0.50ml of supernatant and drop into 7.0ml of distilled water, then add 1.0ml of Nessler's reagent. After standing at room temperature for 10 min, the absorbance was measured with a spectrophotometer (at 480 nm) with a blank tube as a control. After a series of free enzymes with different concentrations are measured by the same method as above, the relationship between the free enzyme concentration and absorbance is calculated, and a calibration curve is made to obtain a linear equation. Then, according to this linear equation (y=0.4286x+0.0555), calculate the enzyme activity actually measured in the immobilized enzyme sample, finally divide the added total amount of enzyme in the sample by the actual enzyme activity in the sample to obtain the recovery rate of the immobilized enzyme activity , the results are shown in Table 3. It can be seen from the table that the recovery rate of immobilized L-asparaginase activity is above 13%, and the highest can reach 76%.
表3固定化L-天冬酰胺酶的活性回收率The active recovery rate of table 3 immobilized L-asparaginase
实施例四:Embodiment four:
与实施例一制备方法相同,将1.5~3.5%的水溶性丝素溶液与青霉素酰化酶混合后,加入快速搅动的过量丙酮(最终体积70%以上)中,其余制备步骤全部相同。用这种丙酮处理方法分别制备得到固定化青霉素酰化酶丝素纳米颗粒悬浮液或冻干粉,其活性测定方法以及固定化酶的活性回收率见表4。表中数值均为5次重复测定的平均值。The preparation method is the same as that in Example 1. After mixing 1.5-3.5% water-soluble silk fibroin solution with penicillin acylase, add it to rapidly stirred excess acetone (final volume above 70%), and the rest of the preparation steps are the same. The acetone treatment method was used to prepare the immobilized penicillin acylase silk fibroin nanoparticle suspension or freeze-dried powder, and the activity determination method and the activity recovery rate of the immobilized enzyme are shown in Table 4. The values in the table are the average value of 5 repeated determinations.
应用PDAB(P-dimethylaminobenzaldehyde)方法测定青霉素酰化酶(penicillin Acylase E.C.3.5.11)的活性(Balasshingham K,Warburton D,Dunnill P et al.,The isolation and kinetics of penicillin amidase fromEscherischia Coli.,Biochim Biophys Acta,1972,276:250-256)。青霉素酰化酶(1000U/mL)在37℃裂解青霉素产生6-APA在酸性条件下,进而与PDAB形成西夫碱,在415nm有最大吸收。酶活测定操作步骤如下:酶液0.5ml或固定化酶约20mg加入到4.5ml磷酸盐缓冲液(pH 7.8)稀释。吸取1.0ml置试管中,于37℃平衡5min。另将4%的青霉素G溶液于37℃平衡5min,吸取1.0ml加入上述含酶的试管中,摇匀,准确反应5min,加入3ml乙醇中止反应。吸取0.75ml加入5.25ml PDAB生色液,放置3min。在415nm处测定光密度.对照标准曲线得6-APA浓度。在pH 7.8,温度37℃条件下每分钟催化青霉素G钾盐水解产生1μmol的6-APA所需的酶量,定义为1个酶活单位(U)。The activity of penicillin acylase (penicillin Acylase E.C.3.5.11) was determined by PDAB (P-dimethylaminobenzaldehyde) method (Balasshingham K, Warburton D, Dunnill P et al., The isolation and kinetics of penicillin amidase from Escherischia Coli., Biochim Biophys Acta , 1972, 276:250-256). Penicillin acylase (1000U/mL) cleaves penicillin at 37°C to produce 6-APA under acidic conditions, and then forms Schiff base with PDAB, with maximum absorption at 415nm. The operation steps of enzyme activity determination are as follows: 0.5ml of enzyme solution or about 20mg of immobilized enzyme is added to 4.5ml of phosphate buffer (pH 7.8) for dilution. Draw 1.0ml into a test tube and equilibrate at 37°C for 5min. In addition, equilibrate 4% penicillin G solution at 37°C for 5 minutes, draw 1.0ml into the test tube containing the enzyme, shake well, react accurately for 5 minutes, and add 3ml of ethanol to stop the reaction. Draw 0.75ml and add 5.25ml PDAB chromogenic solution, let stand for 3min. Measure the optical density at 415nm. Control the standard curve to obtain the concentration of 6-APA. The amount of enzyme required to catalyze the hydrolysis of penicillin G potassium salt to produce 1 μmol of 6-APA per minute at pH 7.8 and temperature 37°C is defined as 1 enzyme activity unit (U).
配制一系列不同浓度的青霉素酰化酶,按上述方法测定酶活性,计算酶浓度与吸光度的标准曲线,求出线性方程y=0.0984x+0.2526,然后计算实际样品中测得的酶活性,根据样品制备时加入的酶量计算固定化酶活性回收率。结果表明,固定化青霉素酰化酶的活性回收率在20~80%之间。Prepare a series of penicillin acylase with different concentrations, measure the enzyme activity according to the above method, calculate the standard curve of enzyme concentration and absorbance, obtain the linear equation y=0.0984x+0.2526, then calculate the enzyme activity measured in the actual sample, according to The amount of enzyme added during sample preparation was used to calculate the recovery rate of immobilized enzyme activity. The results showed that the recovery rate of the activity of the immobilized penicillin acylase was between 20% and 80%.
表4.固定化青霉素酰化酶丝素纳米颗粒的酶活性回收率Table 4. Enzyme activity recovery rate of immobilized penicillin acylase silk fibroin nanoparticles
Claims (2)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100391918A CN100427593C (en) | 2006-03-30 | 2006-03-30 | Enzyme-immobilized silk fibroin nanoparticles and preparation method thereof |
| PCT/CN2007/001032 WO2007112679A1 (en) | 2006-03-30 | 2007-03-29 | Silk fibroin nanoparticles fixed with enzyme and their production |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100391918A CN100427593C (en) | 2006-03-30 | 2006-03-30 | Enzyme-immobilized silk fibroin nanoparticles and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1834240A CN1834240A (en) | 2006-09-20 |
| CN100427593C true CN100427593C (en) | 2008-10-22 |
Family
ID=37002137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100391918A Expired - Fee Related CN100427593C (en) | 2006-03-30 | 2006-03-30 | Enzyme-immobilized silk fibroin nanoparticles and preparation method thereof |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN100427593C (en) |
| WO (1) | WO2007112679A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101168763B (en) * | 2007-11-09 | 2011-07-13 | 重庆理工大学 | Method for preparing nano natural silk protein powder |
| US8389526B2 (en) | 2009-08-07 | 2013-03-05 | Novartis Ag | 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
| WO2014067933A1 (en) * | 2012-10-31 | 2014-05-08 | C-Lecta Gmbh | Bioactive carrier preparation for enhanced safety in care products and food |
| WO2015048527A1 (en) | 2013-09-27 | 2015-04-02 | Tufts University | Optically transparent silk hydrogels |
| CN106822038B (en) * | 2017-01-22 | 2020-08-07 | 厦门大学 | Preparation method and application of enzyme-coated silk nanospheres |
| CA3071086A1 (en) * | 2017-08-18 | 2019-02-21 | The Procter & Gamble Company | Cleaning agent |
| US20210041448A1 (en) * | 2018-04-19 | 2021-02-11 | The University Of Tokyo | Method and kit for assisting diagnosis of disease in subject |
| CN109337892B (en) * | 2018-11-27 | 2021-11-19 | 贺州学院 | Method for immobilizing taro polyphenol oxidase by using fibroin |
| IT201900014607A1 (en) | 2019-08-09 | 2021-02-09 | Sapienza Univ Di Roma | Nanofibroin and compositions containing it for cosmetic applications |
| CN111019932B (en) * | 2019-11-28 | 2023-11-14 | 湖南大学 | Preparation method of copper phosphate-enzyme mineralization material and its products and applications |
| CN115715590B (en) * | 2022-11-18 | 2024-03-29 | 南昌大学 | Preparation method of controlled-release targeted nattokinase-puerarin gel microsphere |
| CN119570776B (en) * | 2024-10-23 | 2025-12-02 | 中山大学·深圳 | A biological enzyme immobilization medium that can be prepared in various forms and its preparation method |
| CN120093629A (en) * | 2025-05-07 | 2025-06-06 | 湖州嘉亨实业有限公司 | A kind of silk fibroin extract, preparation method and application in cosmetics |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4233211A (en) * | 1978-11-13 | 1980-11-11 | Kanebo, Ltd. | Finely powdered fibroin and process for producing same |
| JP2004315682A (en) * | 2003-04-17 | 2004-11-11 | Fukushima Prefecture | Method for producing silk fibroin powder of wild silkworm and silkworm |
| CN1560136A (en) * | 2004-03-04 | 2005-01-05 | 苏州大学 | The manufacture method of nano silk fibroin particle |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5618590A (en) * | 1979-07-20 | 1981-02-21 | Kanebo Ltd | Production of immobilized protease |
| JPH01313530A (en) * | 1988-06-10 | 1989-12-19 | Terumo Corp | Preparation of silk fibroin powder |
-
2006
- 2006-03-30 CN CNB2006100391918A patent/CN100427593C/en not_active Expired - Fee Related
-
2007
- 2007-03-29 WO PCT/CN2007/001032 patent/WO2007112679A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4233211A (en) * | 1978-11-13 | 1980-11-11 | Kanebo, Ltd. | Finely powdered fibroin and process for producing same |
| JP2004315682A (en) * | 2003-04-17 | 2004-11-11 | Fukushima Prefecture | Method for producing silk fibroin powder of wild silkworm and silkworm |
| CN1560136A (en) * | 2004-03-04 | 2005-01-05 | 苏州大学 | The manufacture method of nano silk fibroin particle |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007112679A1 (en) | 2007-10-11 |
| CN1834240A (en) | 2006-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007112679A1 (en) | Silk fibroin nanoparticles fixed with enzyme and their production | |
| Zhang et al. | Formation of silk fibroin nanoparticles in water-miscible organic solvent and their characterization | |
| Cipolatti et al. | Current status and trends in enzymatic nanoimmobilization | |
| Sangeetha et al. | Preparation and characterization of cross-linked enzyme aggregates (CLEA) of subtilisin for controlled release applications | |
| CN1243059C (en) | Manufacture process of nano fibroin partical | |
| WO2021008171A1 (en) | Amphiphilic starch nanoparticles and preparation method therefor | |
| Jafary et al. | Stability improvement of immobilized alkaline phosphatase using chitosan nanoparticles | |
| CN111438368B (en) | Gold-platinum bimetallic nanoenzyme prepared from silk fibroin solution and application thereof | |
| CN101168763A (en) | A kind of preparation method of nano silk fibroin protein powder | |
| CN101244277A (en) | Silk fibroin drug-loaded microspheres and preparation method thereof | |
| CN112056310B (en) | A kind of DFNS supported carbon quantum dot/molybdenum disulfide quantum dot and its preparation method and application | |
| CN112933251B (en) | Preparation method and application of mangano-manganic oxide nano-particles | |
| CN102344686A (en) | Method for preparing fibroin nanoparticles taking polyvinyl alcohol as stabilizer | |
| Zhang et al. | Highly efficient processing of silk fibroin nanoparticle-l-asparaginase bioconjugates and their characterization as a drug delivery system | |
| WO2020259018A1 (en) | Self-assembled catalase nanoparticle, and preparation method therefor and use thereof | |
| CN115646486A (en) | A kind of graphene supported palladium nanozyme and its preparation method and application | |
| CN109810969B (en) | Method for constructing artificial multienzyme system based on lanthanide nucleotide complex and DNA directional immobilization technology | |
| Rani et al. | Alkaline protease mediated bioproteolysis of jasmine oil activated Pennisetum glaucum amylase loaded BSA nanoparticles for release of encapsulated amylase | |
| WO2018214619A1 (en) | Controlled release material for fouling organism-sensitive response anti-fouling agent, and method for manufacturing same | |
| Na Nakorn | Chitin nanowhisker and chitosan nanoparticles in protein immobilization for biosensor applications | |
| CN110777133B (en) | Co-crosslinking immobilization method of lysozyme | |
| CN118791753B (en) | A porous catalytic hydrogel with high enzyme loading capacity, its preparation method and application | |
| CN114288266B (en) | Mucus penetrating type soybean protein nano-particles and preparation method and application thereof | |
| CN101407586B (en) | A kind of nano silver/dextran gel hybrid material and its preparation method and application | |
| Tan et al. | Effect of linoleic-acid modified carboxymethyl chitosan on bromelain immobilization onto self-assembled nanoparticles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081022 Termination date: 20110330 |


